π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The purpose of this study is to evaluate the clinical efficacy of alpha-blo...
Status
Unknown
Location
Soon Chun Hyang University Hospital Cheonan
Start Date
2012-02
Trial ID
NCT01736033
Treatments Being Tested
This study is an open-label, randomized, single dose, multi-stage, cross-ov...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-06
Trial ID
NCT01495026
Treatments Being Tested
This is a multicentre, randomised, double-blind, parallel group study in As...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-10
Trial ID
NCT02058368
To compare the relative bioavailability and pharmacokinetic characteristics...
Status
Completed
Location
Clinical trial center of Anam Hospital
Start Date
2012-01
Trial ID
NCT01829893
Treatments Being Tested
To evaluate the influence of BR9006-1 and BR9006-2 on pharmacokinetics, saf...
Status
Completed
Location
CHA Bundang Medical Center, CHA University
Start Date
2020-07-20
Trial ID
NCT04485585
This study aims to determine the relative bioavailability of tamsulosin hyd...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-06-30
Trial ID
NCT01471678
For patients recovering from acute illness, the ability to stand, walk, cli...
Status
Completed
Location
VA Portland Health Care System, Portland, OR
Start Date
2011-10
Trial ID
NCT01030874
Treatments Being Tested
This study will be an open-label, randomized, single dose, three way crosso...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07-10
Trial ID
NCT02184585
Treatments Being Tested
Study to investigate the efficacy and safety of GL2702 GLARS-NF1tablet and ...
Status
Completed
Location
Eulji general hospital
Start Date
2014-03
Trial ID
NCT02303769
Treatments Being Tested
This study will be an open-label, randomized, single dose, two-period cross...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09-10
Trial ID
NCT01254071